🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Larimar Therapeutics, Inc.

LRMR Healthcare
$3.52 $-0.01 (-0.28%)
Market Cap: $367.43 M
Gurus Holding
4
Popularity Rank
#2513
% of Shares Held
2.51%
Net Activity (Q1 2026)
+$1.61 M

Guru Ownership Trend

Guru Analysis for Larimar Therapeutics, Inc. (LRMR)

Larimar Therapeutics, Inc. (LRMR), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $9.22 M.

Top institutional holders include Steven Cohen and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $1.61 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 148.9%. Conversely, Steven Cohen reduced exposure by 28.3%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$3.47 M
Total Buy Value
New Buys 1
Additions 2
-$1.86 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
1
Net Buyers
3

FAQs for Larimar Therapeutics, Inc. (LRMR)

Major holders include Steven Cohen ($4.71 M), Cliff Asness ($3.68 M), Renaissance Technologies (RenTech) ($3.33 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.62 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.61 M, with 3 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited LRMR. The total reported sell value was $1.86 M.

Yes, 1 managers opened new positions in LRMR, and 2 increased their existing holdings. The total reported buy value was $3.47 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Reduce -28.3% 1,047,385 $4.71 M Q1 2026
0.00% Add 62.8% 817,517 $3.68 M Q1 2026
0.01% Add 148.9% 739,942 $3.33 M Q1 2026
0.00% New Buy 13,065 $58,793 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form